Jeremy David Lack
Directeur/Membre du Conseil chez Alcresta Therapeutics, Inc.
Profil
Dr. Jeremy D.
Lack is a Partner at Athyrium Capital Management (Private Equity) and Athyrium Capital Management LP.
He is on the Board of Directors at Alcresta Therapeutics, Inc. He has broad investment experience in the healthcare sector across a diverse range of asset classes, geographies and transaction types.
Prior to joining Athyrium in 2013, Dr. Lack was a Managing Director at the Cortec Group.
Before Cortec, he was a Principal at New Leaf Venture Partners.
While at NLVP, he was involved with numerous public and private investments in the pharmaceutical, diagnostic, medical device and HCIT spaces.
During his tenure at NLVP, he also founded and led Durata Therapeutics.
Prior to NLVP, he started his investment career as an Associate at Oxford Bioscience Partners and was previously a consultant at McKinsey & Company.
He was also the Director of Strategic Planning for the New York City Department of Education.
Dr. Lack received a Doctorate in Biochemistry from the University of Oxford, where he was a Marshall Scholar, and graduated with honors from the School of Industrial and Labor Relations at Cornell University.
Postes actifs de Jeremy David Lack
| Sociétés | Poste | Début |
|---|---|---|
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Gestionnaire de Portefeuille-Actions | 01/01/2013 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeremy David Lack
| Sociétés | Poste | Fin |
|---|---|---|
Cortec Group Management Services LLC
 Cortec Group Management Services LLC Investment ManagersFinance Cortec Group Management Services LLC (Cortec Group) is private equity firm founded in 1984 by Richard Scott Schafler. The firm is headquartered in New York. | Corporate Officer/Principal | 31/12/2012 |
| DURATA THERAPEUTICS INC | Fondateur | - |
| The New York City Department of Education | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Consultant / Advisor | - |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Analyste en capital-investissement | - |
Formation de Jeremy David Lack
| Cornell University | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Finance |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| The New York City Department of Education | Government |
Cortec Group Management Services LLC
Cortec Group Management Services LLC Investment ManagersFinance Cortec Group Management Services LLC (Cortec Group) is private equity firm founded in 1984 by Richard Scott Schafler. The firm is headquartered in New York. | Finance |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Finance |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |